The quantitative or qualitative G6PD tests that are easy to use and at a cost comparable with the reference spectrophotometry assay or malaria RDT, respectively, should be deployed in remote endemic areas before radical treatment with primaquine or tafenoquine is prescribed. This evidence concerns the gene G6PD and malaria.